NASDAQ
Assembly Biosciences, Inc. (ASMB) reported revenue of $72.30M and net income of $-6,122,000 for FY 2025, with a net profit margin of -8.5%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.